Related Experiment Video
Updated: Apr 7, 2026

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
Published on: January 5, 2016
Elevated Soluble CD14 and Lower D-Dimer Are Associated With Cigarette Smoking and Heavy Episodic Alcohol Use in
Patricia A Cioe1, Jason Baker, Erna M Kojic
1*Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI; †Department of Medicine, University of Minnesota, Hennepin County Medical Center, Minneapolis, MN; ‡Department of Infectious Disease, Brown University, Providence, RI; §Washington University School of Medicine in St. Louis, St. Louis, MO; ‖Denver Infectious Disease Consultants, Denver, CO; and ¶Centers for Disease Control and Prevention, Atlanta, GA.
Insights
Smoking increases inflammation and cardiovascular risk in people with HIV. Quitting smoking is crucial for improving health outcomes and reducing mortality, especially from heart disease.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Infectious Diseases
Background:
- Individuals with HIV face heightened cardiovascular disease (CVD) risk due to chronic inflammation and coagulation.
- Understanding lifestyle factors impacting these processes is vital for managing HIV-related comorbidities.
Purpose of the Study:
- To investigate the association between smoking and heavy episodic alcohol consumption with monocyte activation and coagulation in people with HIV.
- To quantify the impact of these behaviors on specific biomarkers of inflammation and clotting.
Main Methods:
- Prospective observational cohort study (SUN Study) including 689 participants.
- Regression analysis was used to assess the relationship between smoking status, heavy alcohol use, and biomarkers (soluble CD14, D-dimer).
Main Results:
- Current smoking was significantly associated with elevated soluble CD14 levels, indicating increased monocyte activation.
- Heavy episodic alcohol use was linked to significantly lower D-dimer levels, suggesting reduced coagulation activation.
Conclusions:
- Smoking cessation interventions are strongly recommended for HIV care providers to improve overall mortality.
- Reducing smoking can mitigate cardiovascular disease risk and enhance survival outcomes in the HIV-positive population.
Background:
Persons living with HIV are at increased risk for cardiovascular disease in part because of persistent inflammation and coagulation activation.
Methods:
We examined whether smoking and heavy episodic alcohol use (defined as 5 or more drinks on one occasion) were associated with greater monocyte activation (soluble CD14) and coagulation (D-dimer) in participants in the Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (the "SUN" Study), a prospective observational cohort.
Results:
Using regression analysis (n = 689), current smoking compared with nonsmoking was associated with significantly elevated soluble CD14 (B = 135.57, 95% confidence interval: 84.95 to 186.19, P < 0.001), whereas heavy alcohol use compared with nonheavy use was associated with significantly lower D-dimer levels (B = -0.059, 95% confidence interval: -0.102 to -0.016, P = 0.007).
Conclusions:
Smoking cessation should be encouraged by HIV care providers to improve mortality outcomes from all causes of death, particularly cardiovascular disease.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Coronary Artery Disease I: Introduction
Stress Prevention and Stress Management Techniques IV
Atherosclerosis III: Management
Sexually Transmitted Infections

